NRX PHARMACEUTICALS INC's ticker is and the CUSIP is 629444950. A total of 3 filers reported holding NRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 800 | +14.3% | 0.00% | – |
| Q2 2023 | $0 | – | 700 | +600.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 100 | -90.0% | 0.00% | – |
| Q4 2022 | $1 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1,000 | +42.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 700 | -96.6% | 0.00% | – |
| Q1 2022 | $49,000 | -71.3% | 20,400 | -43.0% | 0.00% | – |
| Q4 2021 | $171,000 | – | 35,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 25,600 | $15,000 | 0.00% |
| SIMPLEX TRADING, LLC | 700 | $0 | 0.00% |